Carbamazepine Tablet, Extended Release
Product Images NDC 70771-1468

4 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70771-1468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 01)

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 01)
Chemical structure of carbamazepine, showing a tricyclic ring system with an amide group attached.*
FDA Label Image

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 02)

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 02)
Label for Carbamazepine Extended-Release Tablets, USP 100 mg by Zydus Lifesciences Limited. The packaging indicates 100 film-coated extended-release tablets, Rx only. It includes dosage form and strength, storage instructions to keep between 20° to 25°C, and safety warnings including dispensing advice and child safety. The label also features the NDC 70771-1468-1 and manufacturer details for Zydus Lifesciences Ltd., Ahmedabad, India.*
FDA Label Image

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 03)

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 03)
Label for Carbamazepine Extended-Release Tablets USP 200 mg by Zydus Lifesciences Limited. The label indicates 100 tablets per container with instructions to dispense a medication guide separately. It includes storage instructions and warnings to keep out of reach of children. The NDC is 70771-1469-1.*
FDA Label Image

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 04)

Figure (081d9832 D94a 4496 B6c2 60d6218a9a8a 04)
Label for carbamazepine extended-release tablets USP, 400 mg strength, from Zydus Lifesciences Limited. The oral tablets come in a package of 100 count and are film-coated for extended release. The label includes storage instructions, dispensing warnings, dosage notes, and a barcode, with the NDC number 70771-1470-1 clearly visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.